The move followed a brief pause of the Johnson & Johnson vaccine in the U.S. to investigate reports of clots, which NACI officials said Monday have occurred in 17 of the roughly eight million Americans who have received the shot. A health worker wears a protective face mask and gloves as she gives a Johnson & Johnson COVID-19 vaccine to a woman inside a tent in Krakow, Poland, on Saturday. "What we're saying, and what we've been saying all along, is that the mRNA vaccines are the preferred vaccines," said Deeks. "You can't ignore the VITT risk," said Dr. Isaac Bogoch, an infectious diseases physician and member of Ontario's COVID-19 vaccine task force. 2:32Bogoch said the updated NACI guidelines around the Johnson & Johnson vaccine could cause hesitation among some Canadians but that the similar update to AstraZeneca guidelines didn't stop many Canadians from getting it.

Source: CBC News May 03, 2021 18:39 UTC